Contact ETMC | For Health Professionals | About ETMC

Early heart attack detection device implanted

Physicians at the ETMC Cardiovascular Institute have implanted the AngelMed Guardian cardiac monitor and alert system in a Tyler man to help track significant changes in the heart's electrical signal.

 The team at Tyler Cardiovascular ConsultantsPA is among the first in Texas to implant this experimental device that will alert patients to seek medical attention. The study's goal is to determine the safety and effectiveness of the AngelMed Guardian System. "This research study provides an excellent opportunity for some of our patients who are at high risk of having another heart attack," said Greg Murphy, director of clinical research with Tyler CVC PA.

"The device is designed to measure changes in the electrical signal of the heart and alert the patient at the earliest onset of a heart attack so that they can get treatment as soon as possible." According to the American Heart Association, one of every six deaths in the U.S. is attributable to coronary heart disease.

 Each year, an estimated 785,000 Americans will experience a coronary attack for the first time, and 470,000 will have a recurrent attack. The AngelMed Guardian System is comprised of an internal implantable device, a standard pacemaker lead and an external telemetry device.

A programmer also is used to wirelessly program and retrieve data stored in the implantable device. ETMC Tyler is among the first medical facilities to participate in the AngelMed Guardian System trial. To participate in the ALERTS study, patients must meet inclusion criteria.

 For more information on the AngelMed Guardian system or the ALERTS study protocol, contact Tyler CVC at 903-595-5514.